Drug Profile
Deferitrin
Alternative Names: GT 56-252; Iron chelator - SanofiLatest Information Update: 31 Mar 2022
Price :
$50
*
At a glance
- Originator Genzyme Corporation
- Developer Sanofi
- Class Carboxylic acids; Small molecules; Thiazoles
- Mechanism of Action Chelating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Iron overload